IRIS
MINUTO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.650
Totale 15.650
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.650
Totale 15.650
Salva come PNG Salva come JPEG
Città #
Genova 12.252
Rapallo 1.634
Genoa 1.100
Vado Ligure 644
Bordighera 20
Totale 15.650
Salva come PNG Salva come JPEG
Nome #
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 179
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 173
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 161
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 158
Pituitary image: pituicytoma. 155
The pathology of the ulnar nerve in acromegaly. 149
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 148
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 147
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 145
Diagnostic value of the acid-labile subunit in Acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3 144
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 144
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 144
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 143
Computed tomography colonography in acromegaly 141
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 140
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 140
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 140
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 136
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 134
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study 133
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 133
Indirect evidence of hormone abuse. Proof of doping? 132
Initial staging of lymphoma with octreotide and other receptor imaging agents. 131
Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient 130
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 130
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 130
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 129
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 129
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 128
Acromegaly is associated with increased cancer risk: A survey in Italy 128
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 126
Characterization of the IGF system in 15 patients with Alstrom syndrome. 125
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. 125
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 125
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 124
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 124
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 123
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 123
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 123
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 123
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 122
Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(R) for the treatment of adult patients with growth hormone deficiency 121
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women 121
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 121
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 119
Growth hormone secretion in pubertal and adult subjects. 119
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 119
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities 118
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 118
Somatostatin receptor scintigraphy in thoracic diseases 117
Sympathovagal imbalance in acromegalic patients 117
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 116
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 115
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 115
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 114
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 113
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 112
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 112
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 111
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 111
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 110
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 110
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 110
Evidence for autocrine mitogenic stimulation by somatomedin- C/insulin-like growth factor I on an established human lung cancer cell line 110
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 110
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 109
Trigger Finger, an Early Musculoskeletal Manifestation of Acromegaly 109
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 108
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 107
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. 106
Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. 105
Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. 104
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 104
Pre-surgical treatment with somatostatin analogues in patients with acromegaly: The case for 103
Somatostatin receptor pathophysiology in the neuroendocrine system 103
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 102
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 101
Is there a real diagnostic impact of elastosonography and contrast-enhanced ultrasonography in the management of thyroid nodules? 100
β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly. 100
Replacement therapy and cardiovascular diseases 99
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: implications for the in vivo visualization during somatostatin receptor scintigraphy. 99
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors 99
Identification of a novel mutation in exon 1 of androgen receptor gene in an azoospermic patient with mild androgen insensitivity syndrome: case report and literature review. 99
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 98
Cost-of-illness study in acromegalic patients in Italy 98
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 98
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 98
Papillary thyroid cancer in a struma ovarii: a report of a rare case 98
Wireless connections in a hospital ward: the WARD-IN-HAND Project 97
The undescended testis. Prevalence and clinical features 97
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 97
Guidelines for acromegaly management: an update. 97
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes 97
Somatostatin receptor distribution and function in immune system 96
Significant tumour shrinkage after 12 months of Lanreotide Autogel-120 mg treatment given first-line in acromegaly 96
Novel chimeric somatostatin analogs: facts and perspectives 96
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 96
Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. 95
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 95
Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly 95
Totale 11.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.300
article - articoli 39.777
book - libri 0
conference - conferenze 1.728
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 795
Totale 84.600
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.485 0 0 0 0 390 456 654 266 384 715 448 172
2020/20211.030 70 101 76 79 82 75 63 108 94 116 78 88
2021/20221.870 35 98 169 234 72 128 134 435 90 175 58 242
2022/20231.947 178 143 37 227 313 353 3 132 303 5 228 25
2023/2024787 41 106 12 115 66 128 51 46 47 14 58 103
2024/2025666 53 184 77 173 179 0 0 0 0 0 0 0
Totale 15.698